Close

CASI Pharma's (CASI) Registration App for EVOMELA Accepted by China's FDA

December 5, 2016 7:17 AM EST Send to a Friend
CASI Pharmaceuticals, Inc. (Nasdaq: CASI) announced that China's Food and Drug Administration (CFDA) has accepted for review the Company's import ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login